Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
March 22, 2023
Tickers
LLY
RHHBY
Tags
Market News
Benzinga
General
From
Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
March 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Benzinga
Briefs
From
Benzinga
Is Roche a Buy Now?
March 20, 2023
Tickers
RHHBY
Tags
Recent Press Releases
RHHBY
Market News
From
Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
Tickers
RHHBY
SRPT
Tags
Briefs
Movers
Market News
From
Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
March 09, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
RHHVF
General
From
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
Tickers
APVO
BEAM
CMRX
DVAX
Tags
Market News
ITOS
CMRX
From
InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
Tickers
EXEL
RHHBF
RHHBY
RHHVF
Tags
Large Cap
RHHBY
RHHBF
From
Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
March 02, 2023
Tickers
RHHBY
SRPT
Tags
Market News
SRPT
RHHBY
From
Motley Fool
3 Best Growth Stocks to Buy In March
March 02, 2023
Tickers
HIMS
IWF
MELI
RHHBY
Tags
SRPT
MELI
RHHBY
From
Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
February 27, 2023
Tickers
BPMC
RHHBY
Tags
General
Market News
Benzinga
From
Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
February 23, 2023
Tickers
BPMC
RHHBF
RHHBY
RHHVF
Tags
Biotech
Benzinga
Briefs
From
Benzinga
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
February 23, 2023
Tickers
ABBV
INFI
MEIP
MRK
Tags
News
INFI
General
From
Benzinga
New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder
February 10, 2023
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
REGN
Biotech
Briefs
From
Benzinga
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
February 07, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
News
Briefs
From
Benzinga
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
February 02, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
Earnings
Large Cap
From
Benzinga
Roche Introduces Test To Detect Contagious XBB.1.5 Omicron Sub-Variant
January 26, 2023
Tickers
RHHBF
RHHBY
Tags
RHHBF
Market News
Briefs
From
Benzinga
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
January 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Briefs
Benzinga
From
Benzinga
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
January 17, 2023
Tickers
AERG
ATLX
CLNV
CYDY
Tags
Markets
ATLX
ETHE
From
Benzinga
Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
January 12, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHBY
Large Cap
From
Benzinga
Twitter Hackers Stole More Than 200M Emails, Delta Air Lines To Offer Free Wi-Fi, Bed Bath & Beyond's Bankruptcy Coming Sooner Than Expected: Top Stories Today
January 06, 2023
Tickers
BBBY
CRM
DAL
PFE
Tags
SSNLF
Health Care
Commodities
From
Benzinga
Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review
January 06, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Briefs
Benzinga
From
Benzinga
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
January 02, 2023
Tickers
GILD
RHHBY
Tags
GILD
RHHBY
Recent Press Releases
From
Motley Fool
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Health Care
News
From
Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
Tickers
LLY
RHHBF
RHHBY
RHHVF
Tags
Biotech
Benzinga
Briefs
From
Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
Tickers
GILD
MRK
RCUS
RHHBY
Tags
Market News
NASDAQ:GILD,NYSE:RCUS,OTCMKTS:RHHBY,NYSE:MRK
Today's Market
From
InvestorPlace
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
December 13, 2022
Tickers
AAUKF
ASMIY
ATLX
BDRBF
Tags
ATLX
ETHE
Markets
From
Benzinga
Roche Presents New Data Demonstrating Potential Benefit Of Two Lymphoma Candidates
December 12, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
RHHBY
From
Benzinga
Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12
December 12, 2022
Tickers
AAL
AMGN
AMKBY
AMZN
Tags
EADSY
GOOGL
Tech
From
Benzinga
After 16 Years, Roche's Pharma Division Head Decides To Step Down
December 12, 2022
Tickers
NSRGY
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Health Care
General
From
Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
Tickers
EXEL
IPSEY
RHHBY
TAK
Tags
Biotech
News
EXEL
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.